SEC Form 4 · accession 0001567619-18-007046

Loxo Oncology, Inc. · LOXO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Joshua H. Bilenker

Officer — President & CEO · Director

Period of report

Nov 26, 2018

Accepted (ET)

Nov 28, 2018 · 5:08 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001581720

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Nov 26, 2018	M	29,000	$1.184	A	164,407	D
Common Stock	Nov 26, 2018	M	8,514	$3.648	A	172,921	D
Common Stock	Nov 26, 2018	M	1,486	$13.67	A	174,407	D
Common Stock^F2,F3	Nov 26, 2018	S	800	$150.99	D	173,607	D
Common Stock^F2,F4	Nov 26, 2018	S	3,655	$152.04	D	169,952	D
Common Stock^F2,F5	Nov 26, 2018	S	1,995	$152.75	D	167,957	D
Common Stock^F2,F6	Nov 26, 2018	S	676	$154.07	D	167,281	D
Common Stock^F2,F7	Nov 26, 2018	S	2,210	$155.08	D	165,071	D
Common Stock^F2,F8	Nov 26, 2018	S	664	$156.20	D	164,407	D
Common Stock	Nov 27, 2018	M	10,000	$13.67	A	174,407	D
Common Stock^F2,F9	Nov 27, 2018	S	2,329	$137.92	D	172,078	D
Common Stock^F2,F10	Nov 27, 2018	S	2,638	$138.94	D	169,440	D
Common Stock^F2,F11	Nov 27, 2018	S	700	$140.14	D	168,740	D
Common Stock^F2,F12	Nov 27, 2018	S	690	$141.48	D	168,050	D
Common Stock^F2,F13	Nov 27, 2018	S	634	$142.45	D	167,416	D
Common Stock^F2,F14	Nov 27, 2018	S	859	$143.35	D	166,557	D
Common Stock^F2,F15	Nov 27, 2018	S	700	$144.61	D	165,857	D
Common Stock^F2,F16	Nov 27, 2018	S	600	$147.09	D	165,257	D
Common Stock^F2,F17	Nov 27, 2018	S	250	$148.06	D	165,007	D
Common Stock^F2,F18	Nov 27, 2018	S	400	$149.25	D	164,607	D
Common Stock	Nov 27, 2018	S	200	$151.56	D	164,407	D
Common Stock	holding	—	—		—	30,000	I	By Joshua H. Bilenker, ttee Joshua Bilenker 2018 GRAT, dated 06/20/2018

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F19	$1.184	Nov 26, 2018	M	29,000	D	—	Nov 14, 2023	Common Stock	29,000	27,459	D
Employee Stock Option (Right to Buy)^F20	$3.684	Nov 26, 2018	M	8,514	D	—	Jun 18, 2024	Common Stock	8,514	64,471	D
Employee Stock Option (Right to Buy)^F21	$13.67	Nov 26, 2018	M	1,486	D	—	Dec 18, 2024	Common Stock	1,486	348,514	D
Employee Stock Option (Right to Buy)^F21	$13.67	Nov 27, 2018	M	10,000	D	—	Dec 18, 2024	Common Stock	10,000	338,514	D

Explanation of responses

F1The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F10The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.48 to $139.38 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.77 to $140.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.99 to $141.94 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F14The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.04 to $143.69 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F15The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.14 to $145.13 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F16The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.84 to $147.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F17The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.99 to $148.11 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F18The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.99 to $149.71 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F19The options have fully vested and are immediately exercisable.
F2Represents the aggregate of sales effected on the same day at different prices.
F20The stock option vests and becomes exercisable in 48 equal monthly installments beginning on the vesting commencement date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F21The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the vesting commencement date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F3The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.45 to $151.23 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.50 to $152.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.50 to $153.39 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.51 to $154.39 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.53 to $155.52 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.68 to $156.60 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.45 to $138.38 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.